" /> TriGem - CISMeF





Preferred Label : TriGem;

NCIt definition : An anti-idiotype monoclonal antibody that mimics the disialoganglioside GD2, a cancer-associated antigen present on melanoma, small cell lung cancer, sarcoma, neuroblastoma and other malignancies. GD2 is a highly expressed glycosphingolipid by melanoma and other neuroectodermal tumors with only minimal expression on normal tissues. TriGem induces an immune response and can be the base for immunotherapy of melanoma and other cancers. (NCI04);

NCIt note : A monoclonal antibody directed against I17, proposed for treatment of advanced cancers expressing GD2 ganglioside;

Détails


Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.